Factotum hematologist at Boston Medical Center
Associate Professor at Chobanian and Avedisian School of Medicine.
Program director for the hematology/oncology fellowship at Boston University.
I see patients with a variety of benign and malignant blood disorders.
I have particular research interests in AL Amyloidosis, HTLV-1 associated leukemia/lymphoma (ATLL)
Diversity, Equity, Inclusion and Accessibility
Our medical center is dedicated to the idea that all people merit respect and access to high quality health care. Additionally, everyone deserves fair access to representation in clinical trials and research that will shape future medical care. We welcome and celebrate individuals of all races, ethnicities, social backgrounds, religion, gender, sex, age, ability, sexual orientation and national origin.
Member
Boston University
BU-BMC Cancer Center
Member
Boston University
Amyloidosis Center
Member
Boston University
Evans Center for Interdisciplinary Biomedical Research
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
-
Freydman J, Staron A, Hughes D, Sloan JM. Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome. J Oncol Pharm Pract. 2023 Sep; 29(6):1489-1493.View Related Profiles. PMID: 37157792
-
Hassan H, Verma K, Ferri G, Brauneis D, Quillen K, Sloan JM, Sanchorawala V, Edwards CV. Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Transplant Cell Ther. 2022 Nov; 28(11):761.e1-761.e7.View Related Profiles. PMID: 35970300
-
Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles. PMID: 35731907
-
Hughes DM, Henshaw L, Blevins F, Edwards C, Lerner A, Sloan JM, Sanchorawala V. Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22(8):566-568.View Related Profiles. PMID: 35367193
-
Milrod CJ, Mann M, Blevins F, Hughes D, Patel P, Li KY, Lerner A, Sanchorawala V, Sloan JM. Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma. Crit Rev Oncol Hematol. 2022 Apr; 172:103644.View Related Profiles. PMID: 35227897; DOI: 10.1016/j.critrevonc.2022.103644;
-
Gupta VK, El-Jawahri A, Orkev G, Johnson MH, Weinberg J, Goodrich C, Janakiram M, Sloan JM. Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation. Transplant Cell Ther. 2022 May; 28(5):276.e1-276.e5.View Related Profiles. PMID: 35123118; PMCID: PMC9969520; DOI: 10.1016/j.jtct.2022.01.023;
-
Furtado VF, Brauneis D, Weinberg J, Elhassan N, Sloan JM, Sanchorawala V. Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis. Bone Marrow Transplant. 2022 02; 57(2):306-308.View Related Profiles. PMID: 34845368
-
Szalat RE, Gustine J, Sloan JM, Edwards CV, Sanchorawala V. Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. Am J Hematol. 2022 01 01; 97(1):79-89.View Related Profiles. PMID: 34739735
-
Charidimou A, Samudrala S, Cervantes-Arslanian AM, Sloan JM, Dasenbrock HH, Daneshmand A. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106113.View Related Profiles. PMID: 34547677
Showing 10 of 77 results.
Show More
-
-
Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 05 27; 137(21):2987-2989.View Related Profiles. PMID: 33728443
-
Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2021 03 01; 41(1):e77-e78.View Related Profiles. PMID: 32235225
-
Hughes DM, DeMari S, Hassan H, Sanchorawala V, Sloan JM. Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):e460-e463.View Related Profiles. PMID: 33716055
-
-
Gupta VK, Strykowski R, Scarpato B, Lawrence R, Khan SL, Patel J, Nouraie SM, Cohen RT, Sloan JM, Klings ES. The effect of anticoagulant choice on venous thromboembolism recurrence and bleeding in sickle cell disease. Am J Hematol. 2020 Oct; 95(10):E279-E281.View Related Profiles. PMID: 32619024
-
Szalat R, Sarosiek S, Havasi A, Brauneis D, Sloan JM, Sanchorawala V. Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia. 2021 03; 35(3):916-919.View Related Profiles. PMID: 32737434
-
Dumas B, Yameen H, Sarosiek S, Sloan JM, Sanchorawala V. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen. Amyloid. 2020 Dec; 27(4):244-249.View Related Profiles. PMID: 32551974
-
Sanchorawala V, Sarosiek S, Schulman A, Mistark M, Migre ME, Cruz R, Sloan JM, Brauneis D, Shelton AC. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study. Blood. 2020 04 30; 135(18):1541-1547.View Related Profiles. PMID: 31978210; PMCID: PMC7193185; DOI: 10.1182/blood.2019004436;
-
-
Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol. 2020 02; 95(2):E45-E48.View Related Profiles. PMID: 31736101
-
Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319.View Related Profiles. PMID: 31489689
-
Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. Am J Hematol. 2019 10; 94(10):1098-1103.View Related Profiles. PMID: 31292986
-
Sloan JM. Lessons in Long Term Survival from AL Amyloidosis. Br J Haematol. 2019 12; 187(5):557-558. PMID: 31290565
-
Singh P, Chen H, Gordon CE, Ghai S, Sloan JM, Quillen K, Moradi S, Chitalia V, Gautam A, Henderson J, Francis JM. Monoclonal IgG4/2? Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation. Kidney Med. 2019 May-Jun; 1(3):139-143.View Related Profiles. PMID: 32734194; PMCID: PMC7380410; DOI: 10.1016/j.xkme.2019.03.005;
-
Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637.View Related Profiles. PMID: 31018069
-
-
Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309.View Related Profiles. PMID: 30664726
-
Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 05; 25(5):e169-e173.View Related Profiles. PMID: 30639823
-
Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 03; 94(3):E80-E82.View Related Profiles. PMID: 30575098
-
Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019 02; 95(2):405-411.View Related Profiles. PMID: 30580886
-
Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827.View Related Profiles. PMID: 29933072; PMCID: PMC7553205; DOI: 10.1016/j.bbmt.2018.06.018;
-
Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 08 16; 132(7):755-757.View Related Profiles. PMID: 29903887
-
White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 12; 53(12):1593-1595.View Related Profiles. PMID: 29884854
-
Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Jun; 57(3):411-415.View Related Profiles. PMID: 29731423
-
Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study. JAMA Dermatol. 2018 02 01; 154(2):182-187. PMID: 29238798; PMCID: PMC5839276; DOI: 10.1001/jamadermatol.2017.4920;
-
Nguyen VP, Brauneis D, Kaku M, Sloan JM, Sarosiek S, Quillen K, Shelton AC, Sanchorawala V. Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2018 03; 53(3):371-373.View Related Profiles. PMID: 29269794
-
Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Biol Blood Marrow Transplant. 2018 01; 24(1):127-132.View Related Profiles. PMID: 28865972
-
Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, Ruberg FL, Sanchorawala V, Varga C. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017 09; 52(9):1349-1351.View Related Profiles. PMID: 28737773
-
Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM. Thrombotic Microangiopathy: A Multidisciplinary Team Approach. Am J Kidney Dis. 2017 Nov; 70(5):715-721.View Related Profiles. PMID: 28720207
-
Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 09 14; 130(11):1383-1386.View Related Profiles. PMID: 28698204
-
Dittus C, Sloan JM. Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home. Hematol Oncol Clin North Am. 2017 Apr; 31(2):255-272. PMID: 28340877
-
Sarosiek S, Rybin D, Weinberg J, Burke PA, Kasotakis G, Sloan JM. Association Between Inferior Vena Cava Filter Insertion in Trauma Patients and In-Hospital and Overall Mortality. JAMA Surg. 2017 Jan 01; 152(1):75-81.View Related Profiles. PMID: 27682367; DOI: 10.1001/jamasurg.2016.3091;
-
-
-
Dittus C, Uwumugambi N, Sun F, Sloan JM, Sanchorawala V. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Sep; 22(9):1729-1732.View Related Profiles. PMID: 27296954; DOI: 10.1016/j.bbmt.2016.05.027;
-
Muñoz-Largacha JA, O'Hara CJ, Sloan JM, Fernando HC, Litle VR. Surgical Management of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Associated With Light-Chain Deposition Disease. Ann Thorac Surg. 2016 Jun; 101(6):e207-10.View Related Profiles. PMID: 27211983; DOI: 10.1016/j.athoracsur.2015.10.089;
-
Lee SY, Meehan RS, Seldin DC, Sloan JM, Quillen K, Shelton A, Brauneis D, Sanchorawala V. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplant. 2016 Oct; 51(10):1318-1322.View Related Profiles. PMID: 27183092; DOI: 10.1038/bmt.2016.132;
-
Inagaki E, Farber A, Eslami MH, Siracuse JJ, Rybin DV, Sarosiek S, Sloan JM, Kalish J. Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approach. J Vasc Surg Venous Lymphat Disord. 2016 Jul; 4(3):276-82.View Related Profiles. PMID: 27318045; PMCID: PMC5531451; DOI: 10.1016/j.jvsv.2015.11.002;
-
-
-
Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015 Nov 12; 126(20):2345-7.View Related Profiles. PMID: 26443620; DOI: 10.1182/blood-2015-08-662726;
-
Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1445-51.View Related Profiles. PMID: 25858810; DOI: 10.1016/j.bbmt.2015.04.001;
-
Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis. Bone Marrow Transplant. 2014 Oct; 49(10):1345-6.View Related Profiles. PMID: 24955784; DOI: 10.1038/bmt.2014.132;
-
Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1877-84. PMID: 24946718; DOI: 10.1016/j.bbmt.2014.06.009;
-
Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series. Amyloid. 2014 Sep; 21(3):149-53.View Related Profiles. PMID: 24779777; DOI: 10.3109/13506129.2014.900486;
-
-
Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9.View Related Profiles. PMID: 24317129; DOI: 10.1038/bmt.2013.192;
-
Raman V, Quillen K, Sloan JM. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):e51-4.View Related Profiles. PMID: 24342105; DOI: 10.1016/j.clml.2013.10.004;
-
Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med. 2013 Apr 8; 173(7):513-7.View Related Profiles. PMID: 23552968; DOI: 10.1001/jamainternmed.2013.343;
-
Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6.View Related Profiles. PMID: 23175664; DOI: 10.1182/blood-2012-09-457341;
-
-
Perry JH, Lazar HL, Quillen K, Sloan JM. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin. J Card Surg. 2012 Nov; 27(6):730-5.View Related Profiles. PMID: 23173861; DOI: 10.1111/jocs.12010;
-
Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid. 2012 Sep; 19(3):156-60.View Related Profiles. PMID: 22680044; DOI: 10.3109/13506129.2012.694825;
-
Ryan RJ, Sloan JM, Collins AB, Mansouri J, Raje NS, Zukerberg LR, Ferry JA. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series. Am J Clin Pathol. 2012 Jan; 137(1):51-64. PMID: 22180478; DOI: 10.1309/AJCPI08WAKYVLHHA;
-
-
Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52.View Related Profiles. PMID: 21828140; PMCID: PMC3204906; DOI: 10.1182/blood-2011-01-330738;
-
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9.View Related Profiles. PMID: 21838459; PMCID: PMC5601311; DOI: 10.3109/13506129.2011.574354047;
-
-
-
-
Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis. 2009 Jul; 54(1):159-64. PMID: 19185401; PMCID: PMC2724597; DOI: 10.1053/j.ajkd.2008.11.013;
-
Sloan JM, Ballen K. SCT in Jehovah's Witnesses: the bloodless transplant. Bone Marrow Transplant. 2008 May; 41(10):837-44. PMID: 18246110; DOI: 10.1038/bmt.2008.5;
-
Vinaya KN, White RI, Sloan JM. Reassessing bronchial artery embolotherapy with newer spherical embolic materials. J Vasc Interv Radiol. 2004 Mar; 15(3):304-5. PMID: 15028819
-
Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P. MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells. Cancer Gene Ther. 2002 Nov; 9(11):946-50. PMID: 12386833; PMCID: PMC1764124
-
Sloan, JM Seldin, D. Approach to Benign Hematologic Disorders. ACP Medicine. View Publication
-
Sloan JM, Raje, N. Anemia and Erythropoietic Growth Factors in Multiple Myeloma. Multiple Myeloma: Pursuing the Plasma Cell. View Publication
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 2 |
2018 Boston University:
Evans Clinician